Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 11 (RPL29P11)

Target
RPL29P11
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L29 pseudogene 11 (RPL29P11) is a processed pseudogene in the human genome. Pseudogenes are segments of DNA that arise from functional genes but have lost their ability to produce functional proteins, typically due to mutations or loss of regulatory elements. RPL29P11 is one of several pseudogenes related to the ribosomal protein L29 gene (RPL29), which encodes a structural protein of the large 60S ribosomal subunit. Like most ribosomal protein pseudogenes, RPL29P11 does not have any known functional role, biological activity, or direct involvement in disease. It is not a drug target, nor is it considered a biomarker for disease monitoring or therapeutic response. Its primary relevance is genomic annotation rather than medical or functional significance[7][1][3]. The true ribosomal protein L29 is a structural component of the ribosome, but RPL29P11 is a non-coding pseudogene and does not encode this protein[5][3]. It is cataloged in gene databases and may be referenced in studies of genomic structure or pseudogene biology, but not as a receptor, enzyme, transporter, or other classical drug target[7][1].

Other names
RPL29_2_362[1]multiple GeneCards and Ensembl identifiers[7]
02

Biological functions

Other (No known function; not transcribed into functional protein)[7][1]
03

Disease associations

Other (No established disease associations)

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 11 (RPL29P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 11 (RPL29P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call